ArticleIrish journal of medical science2025
Diagnostic and prognostic significance of lncRNA THRIL in gestational diabetes mellitus and the regulation of trophoblastic function.
Article in Irish journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGestational diabetes mellitus (GDM), a common rising pregnancy complications, seriously affects maternal and infant prognosis.
objectivesThis study analyzed the clinical significance of THRIL in GDM patients, as well as explored the potential mechanism by which THRIL regulated the GDM progression through miR-424.
methodsRT-qPCR detected THRIL and miR-424 levels. ROC and logistic regression analyzed diagnostic and predictive significance of THRIL. The dual luciferase assay verified the negative regulatory relationship between THRIL and miR-424. The HTR-8/SVneo high-glucose (HG) injury model was established, and the effects of THRIL overexpression as well as co-overexpression of THRIL and miR-424 on cell behavior were detected using CCK-8, flow cytometry, and Transwell assays.
resultsTHRIL was decreased in serum of GDM patients (P < 0.001), while miR-424 was elevated (P < 0.001), and the two were negatively regulated by each other (r = -0.70, P < 0.01). Serum THRIL had a strong ability to recognize GDM (AUC = 0.92, P < 0.01) and predicted the occurrence of adverse pregnancy outcomes (OR = 12.860, P < 0.001). In the HTR-8/SVneo HG induction model, THRIL overexpression significantly promoted cell proliferation, migration, and invasion, and inhibited apoptosis (P < 0.01). While THRIL and miR-424 co-overexpression effectively eliminated the positive effect of THRIL overexpression on cell behavior (P < 0.01).
conclusionThe down-regulated THRIL inhibits the behavior of trophoblast cells through miR-424, thereby affecting pregnancy outcomes in GDM patients. Serum THRIL is a promising marker for the diagnosis and prediction of GDM.
Indexed as
Identifiers
40788443What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.